COP.HM Compugroup Medical SE & Co. KGaA
- Market cap
- EUR 1.40B
- P/E
- 54.1x
- P/B
- 1.79x
- ROE
- 6.7%
- Dividend yield
- 3.70%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2025.
Is COP.HM undervalued?
Graham numberCOP.HM trades 107.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Compugroup Medical SE & Co. KGaA fundamental analysis
No fundamental analysis for Compugroup Medical SE & Co. KGaA yet.
Compugroup Medical SE & Co. KGaA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Compugroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions t…
Full company profileCompugroup Medical SE & Co. KGaA financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Compugroup Medical SE & Co. KGaA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 560M | 582M | 717M | 746M | 837M | 1.03B | 1.13B | 1.19B | 1.15B | 1.14B |
| Gross Profit | 466M | 492M | 584M | 631M | 713M | 871M | 958M | 1.01B | 965M | 967M |
| Operating Income | 75.2M | 79.8M | 133M | 107M | 125M | 108M | 107M | 123M | 106M | 89.3M |
| EBITDA | - | 111M | 180M | 175M | 192M | 214M | 228M | - | - | - |
| Net Income | 44.5M | 31.3M | 92.3M | 65.8M | 73.2M | 69.0M | 73.4M | 45.9M | 34.6M | 43.7M |
| EPS | - | 0.63 | 1.88 | 1.36 | 1.36 | 1.32 | 1.41 | 0.88 | 0.67 | 0.84 |
| Balance Sheet | ||||||||||
| Total Assets | 808M | 825M | 848M | 1.07B | 1.57B | 1.79B | 1.94B | 1.90B | 1.97B | 2.02B |
| Total Liabilities | 589M | 589M | 575M | 806M | 927M | 1.18B | 1.27B | 1.23B | 1.32B | 1.37B |
| Shareholders' Equity | 218M | 234M | 271M | 259M | 639M | 612M | 672M | 668M | 648M | 651M |
| Cash & Short-term Investments | 25.4M | 26.4M | 19.6M | 43.8M | 74.6M | 107M | 90.5M | 64.4M | 107M | 119M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 67.6M | 85.8M | 136M | 110M | 150M | 165M | 145M | 180M | 129M | 376M |
| Capital Expenditure | 42.4M | 47.1M | 40.4M | 43.7M | 57.8M | 77.5M | 81.0M | 75.4M | 63.2M | 62.6M |
| Free Cash Flow | - | 38.8M | 96.0M | 66.8M | 92.2M | 87.8M | 64.0M | 104M | 65.7M | 313M |
| Ratios | ||||||||||
| ROE | 20.4% | 13.3% | 34.1% | 25.4% | 11.5% | 11.3% | 10.9% | 6.9% | 5.3% | 6.7% |
| ROA | 5.5% | 3.8% | 10.9% | 6.2% | 4.7% | 3.9% | 3.8% | 2.4% | 1.8% | 2.2% |
| Net Profit Margin | 7.9% | 5.4% | 12.9% | 8.8% | 8.7% | 6.7% | 6.5% | 3.9% | 3.0% | 3.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Compugroup Medical SE & Co. KGaA dividends
- Dividend yield
- 3.70%
- Forward dividend
- -
- Payout ratio
- 149.5%
- Ex-dividend date
- Aug 4, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | EUR 51.7M | 1.00 | 149.5% |
| 2023 | EUR 26.1M | 0.50 | 56.9% |
| 2022 | EUR 26.1M | 0.50 | 35.6% |
| 2021 | EUR 26.4M | 0.50 | 38.2% |
| 2020 | EUR 24.2M | 0.45 | 33.1% |
| 2019 | EUR 24.4M | 0.50 | 37.1% |
| 2018 | EUR 17.4M | 0.35 | 18.8% |
| 2017 | EUR 17.4M | 0.35 | 55.7% |
| 2016 | EUR 17.4M | - | 39.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 25:1 on Oct 23, 2006.
Who owns Compugroup Medical SE & Co. KGaA
- Insiders 55.76%
- Institutions 36.67%
- Public & others 7.57%
- Shares outstanding 51.7M
- Free float 19.1M
Compugroup Medical SE & Co. KGaA company profile
- Company name
- Compugroup Medical SE & Co. KGaA
- Ticker
- COP.HM
- ISIN
- DE000A288904
- Exchange
- Hamburg Exchange
- Sector
- -
- Industry
- Metals & Mining
- Employees
- 8,700
- Fiscal year end
- December
- Address
- Maria Trost 21, Koblenz, Germany, 56070
- Phone
- 49 261 8000 0
- Website
- cgm.com
About Compugroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions, as well as internet and intranet solutions for the secure exchange of doctor and patient information; and data-driven products, software interfaces for information exchange, medical decision support tools, pharmaceutical and therapy databases, solutions for the insurance industry, and digital applications and mobile apps, as well as provides facilities for medical care centers and practice associations. Its Hospital Information Systems segment offers clinical and administrative solutions for the inpatient healthcare sector, including the facilitation of patient administration, resource and personnel management, medical-care documentation, billing, and financial and medical controlling; and clinical applications to support specialist departments, medical laboratories and radiology networks. This segment serves acute care hospitals, rehabilitation centers, welfare institutions, hospital networks, medical laboratories, and radiologists. The Pharmacy Information Systems segment provides administrative and billing-related software applications for pharmacies, which supports aspects of the supply chain for medication from procuring and shipping the medication, managing and controlling inventory, through to planning, and performing and monitoring retail activities. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
Compugroup Medical SE & Co. KGaA management
10- Dr. Daniel Gotthardt Ph.D.MD, CEO & Head of Ambulatory Information Systems DACH · born 1973
- Ms. Daniela HommelMD & CFO · born 1975
- Mr. Hannes ReichlChief Operating Officer · born 1976
- Mr. Frank GotthardtChairman of Management Board · born 1950
- Dr. Klaus Esser Ph.D.Vice Chairman of Management Board
- Mr. Daniel Pindur Ph.D.Member of Management Board · born 1978
- Mr. Can ToygarMember of Management Board
- Mr. Christoph RotteleMember of Management Board · born 1970
- Ms. Claudia ThoméCorporate Vice President of Investor Relations · born 1970
- Mr. Helge WeißSenior Vice President of Connectivity